https://ir.fibrobiologics.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_14a954ff2903678ce9699bf59a0e1fd9/fibrobiologics/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.fibrobiologics.com/news-events/press-releases/detail/138/fibrobiologics-announces-issuance-of-new-u-s-patent-for-the-therapeutic-use-of-fibroblasts-in-wound-healing Thu, 03 Sep 26 08:30:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/138/fibrobiologics-announces-issuance-of-new-u-s-patent-for-the-therapeutic-use-of-fibroblasts-in-wound-healing https://ir.fibrobiologics.com/news-events/press-releases/detail/137/fibrobiologics-announces-issuance-of-new-u-s-patent-for-the-treatment-of-degenerative-disc-disease-using-fibroblast-conditioned-media Tue, 01 Sep 26 08:30:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/137/fibrobiologics-announces-issuance-of-new-u-s-patent-for-the-treatment-of-degenerative-disc-disease-using-fibroblast-conditioned-media https://ir.fibrobiologics.com/news-events/press-releases/detail/136/fibrobiologics-releases-third-batch-of-cywc628-drug-product-for-phase-12-diabetic-foot-ulcer-clinical-trial Thu, 27 Aug 26 08:30:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/136/fibrobiologics-releases-third-batch-of-cywc628-drug-product-for-phase-12-diabetic-foot-ulcer-clinical-trial https://ir.fibrobiologics.com/news-events/press-releases/detail/135/fibrobiologics-regains-compliance-with-nasdaq-trading-rules Wed, 26 Aug 26 08:30:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/135/fibrobiologics-regains-compliance-with-nasdaq-trading-rules https://ir.fibrobiologics.com/news-events/press-releases/detail/134/fibrobiologics-appoints-leigh-steinberg-to-board-of-directors Mon, 24 Aug 26 08:30:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/134/fibrobiologics-appoints-leigh-steinberg-to-board-of-directors https://ir.fibrobiologics.com/news-events/press-releases/detail/133/fibrobiologics-announces-australian-patent-accepted-for-cannabidiol-adjuvant-therapy-for-the-treatment-of-degenerative-disc-disease Thu, 20 Aug 26 08:30:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/133/fibrobiologics-announces-australian-patent-accepted-for-cannabidiol-adjuvant-therapy-for-the-treatment-of-degenerative-disc-disease https://ir.fibrobiologics.com/news-events/press-releases/detail/132/fibrobiologics-announces-chondrocyte-spheroids-demonstrate-cartilage-repair-in-preclinical-study-of-degenerative-joints Tue, 18 Aug 26 08:30:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/132/fibrobiologics-announces-chondrocyte-spheroids-demonstrate-cartilage-repair-in-preclinical-study-of-degenerative-joints https://ir.fibrobiologics.com/news-events/press-releases/detail/131/fibrobiologics-granted-u-s-patent-covering-the-use-of-fibroblasts-to-enhance-survival-and-function-of-transplanted-insulin-producing-islets Tue, 11 Aug 26 08:30:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/131/fibrobiologics-granted-u-s-patent-covering-the-use-of-fibroblasts-to-enhance-survival-and-function-of-transplanted-insulin-producing-islets https://ir.fibrobiologics.com/news-events/press-releases/detail/130/fibrobiologics-granted-european-patent-covering-gene-therapy-for-the-regeneration-of-cartilage Wed, 05 Aug 26 08:30:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/130/fibrobiologics-granted-european-patent-covering-gene-therapy-for-the-regeneration-of-cartilage https://ir.fibrobiologics.com/news-events/press-releases/detail/129/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candidate Fri, 31 Jul 26 17:34:00 -0400 https://ir.fibrobiologics.com/news-events/press-releases/detail/129/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candidate